Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
An article published in the March 2016 issue of The American Journal of Managed Care® (AJMC®) was cited in 2 pieces online this week. Yahoo! published “Are Your Hospital Outpatient Department Costs Too High? A Doctor's Office May Help” and Healthcare Finance published “Costs for Common Healthcare Procedures Higher in Hospital Outpatient Departments,” both referencing the findings in “National Estimates of Price Variation by Site of Care” that prices for services performed at hospital outpatient departments were higher than in physician offices.
The National Pharmaceutical Council’s CER Daily Newsfeed for September 19, 2023, highlighted a video interview published on AJMC.com, the website of AJMC. “Dr Ryan Haumschild Discusses Payer, Provider Perspectives on Prior Authorization in Rare Diseases” featured AJMC editorial board member Ryan Haumschild, PharmD, MS, MBA, director of pharmacy at Emory Winship Cancer Institute, sharing his unique perspectives as both a provider and payer on the use of prior authorizations.
POSITIVE Trial Update on Patients With Breast Cancer Attempting Pregnancy
December 8th 2023At last year’s San Antonio Breast Cancer Symposium, POSITIVE trial primary outcome data were presented on breast cancer–free interval, with women who paused endocrine therapy to attempt pregnancy having a similarly small rate of recurrence vs external controls from the SOFT and TEXT trials: 8.9% vs 9.2%.
Read More
Dr Kathryn Lindley on Pregnancy-Related Cardiovascular Care Gaps and Training Initiatives
December 8th 2023Cardiologists need skills in risk assessment, contraception counseling, and hypertension management for pregnant patients, according to Kathryn Lindley, MD, FACC, Vanderbilt University Medical Center.
Read More
Real-World Data Show Poor Outcomes Among Patients With ACS and Blood Cancers
December 8th 2023A real-world analysis found that patients with acute coronary syndrome who were also diagnosed with a hematologic malignancy had worse survival outcomes, and patients with multiple myeloma were overrepresented in the population.
Read More